A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

A Phase IIa, Multicenter, Double-Blind, Randomized, Active-Controlled, Parallel-Arm Clinical Trial to Study the Efficacy and Safety of MK-0941 Compared to Sulfonylurea in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy

The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.

Inclusion Criteria:

• Patient has type 2 diabetes mellitus
• Between the ages of 18 and 70

Exclusion Criteria:

• Patient has a history of type 1 diabetes mellitus or ketoacidosis.
• Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.
• Patient has had surgery within 30 days of starting the study or has planned major surgery during the study